Noori N. Maka

Garscube Estate
Glasgow, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Correction: JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal‑rich.

Correction: JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal‑rich.

Journal: Journal of experimental & clinical cancer research : CR

Published: August 14, 2026

Detection of Fusobacterium nucleatum in Colorectal Adenomas Reveals Associations with Immune Molecular Signatures.

Detection of Fusobacterium nucleatum in Colorectal Adenomas Reveals Associations with Immune Molecular Signatures.

Journal: International journal of molecular sciences

Published: July 01, 2026

Differential Immunologic Effects of Short-Course and Long-Course Radiotherapy in Locally Advanced Rectal Cancer.

Differential Immunologic Effects of Short-Course and Long-Course Radiotherapy in Locally Advanced Rectal Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 23, 2025

Investigation of three alternative histopathological scoring methods at the invasive tumour front in colorectal cancer.

Investigation of three alternative histopathological scoring methods at the invasive tumour front in colorectal cancer.

Journal: The journal of pathology. Clinical research

Published: February 06, 2025

IL6 and IL6R as Prognostic Biomarkers in Colorectal Cancer.

IL6 and IL6R as Prognostic Biomarkers in Colorectal Cancer.

Journal: Biomolecules

Published: November 15, 2024

Decay of driver mutations shapes the landscape of intestinal transformation.

Decay of driver mutations shapes the landscape of intestinal transformation.

Journal: Nature

Published: May 25, 2024

The relationship between tumour necrosis, systemic inflammation, body composition and survival in patients with colon cancer.

The relationship between tumour necrosis, systemic inflammation, body composition and survival in patients with colon cancer.

Journal: BJC reports

Published: April 18, 2024

Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG Studies.

Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG Studies.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 14, 2024

TAK1 expression is associated with increased PD-L1 and decreased cancer-specific survival in microsatellite-stable colorectal cancer.

TAK1 expression is associated with increased PD-L1 and decreased cancer-specific survival in microsatellite-stable colorectal cancer.

Journal: Translational oncology

Published: March 14, 2024

The Glasgow Microenvironment Score: an exemplar of contemporary biomarker evolution in colorectal cancer.

The Glasgow Microenvironment Score: an exemplar of contemporary biomarker evolution in colorectal cancer.

Journal: The journal of pathology. Clinical research

Published: February 08, 2024

JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors.

JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors.

Journal: Journal of experimental & clinical cancer research : CR

Published: September 27, 2023

Histopathological tumour microenvironment score independently predicts outcome in primary operable colorectal cancer.

Histopathological tumour microenvironment score independently predicts outcome in primary operable colorectal cancer.

Journal: The journal of pathology. Clinical research

Published: September 15, 2023

Showing 1-12 of 22

Last Updated: 09/26/2026